Hemispherx Biopharma 8-K Shows Co. On October 9 Executed Clinical Trial Agreement With Roswell Park Comprehensive Cancer Screening; Phase IIa Trial Will Evaluate Immune-Mediated Effects Of Cytokine Modulation In Combination With CPIs In Patients